Low prevalence of invasive adenocarcinoma and occult cancer on esophageal resection for Barrett’s esophagus with high-grade dysplasia: Evidence for conservative management

Due to the variety of therapeutic options that are currently available for patients diagnosed with Barrett’s-related high-grade dysplasia (BE-HGD), the choice of optimal management continues to be a topic of discussion among gastroenterologists, surgeons, oncologists, pathologists, and patients.

http://www.thejgo.org/index.php/jgo/article/view/36/html_29